What is Tarsus Pharmaceuticals, Inc.'s total cost of revenue?

Tarsus Pharmaceuticals, Inc. (TARS) reported total cost of revenue of $9.4M in Q1 2026.

How has Tarsus Pharmaceuticals, Inc.'s total cost of revenue changed year-over-year?

Tarsus Pharmaceuticals, Inc.'s total cost of revenue increased by 80.3% year-over-year, from $5.21M to $9.4M.

What does total cost of revenue mean?

The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.

Tarsus Pharmaceuticals, Inc. TARS Total Cost of Revenue

Total Cost of Revenue at other companies

AbbVieABBV

$4.22B+5.4%

Warby ParkerWRBY

$111.41M+13.9%

GlaukosGKOS

$33.34M+37.1%

Regeneron PharmaceuticalsREGN

——

Segments

By segment

See full

Reportable Segment$9.4M+80.3%

Other financials

Income statement

See full

Revenue$162.1M+107%

Gross profit$152.7M+109%

Operating income-$6.1M+76.7%

Net income-$7.0M+72.3%

EPS (diluted)-$0.16+75.0%

Balance sheet

See full

Cash & equivalents$104.2M-41.6%

Total debt$88.7M+22.5%

Total equity$349.0M+1.9%

Total assets$581.1M+16.1%

Cash flow

See full

Operating cash flow-$24.7M-19.4%

CapEx$5.8M+886%

Free cash flow-$30.5M-43.4%

Valuation

See full

Market cap$2.85B+41.1%

Enterprise value$2.83B+47.8%

P/S5.3×-3.3×

Profitability

See full

Gross margin42.7%—

Operating margin-9.5%-4.2pp

Net margin-9%-4.0pp

FCF margin-28%-12.6pp

Returns & leverage

See full

Return on equity-14%-5.2pp

Debt / equity0.3×0.0×

Current ratio3.7×-1.8×

Where this comes from

Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tarsus Pharmaceuticals, Inc.'s total cost of revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tarsus Pharmaceuticals, Inc.'s total cost of revenue?: Tarsus Pharmaceuticals, Inc. (TARS) reported total cost of revenue of $9.4M in Q1 2026.
How has Tarsus Pharmaceuticals, Inc.'s total cost of revenue changed year-over-year?: Tarsus Pharmaceuticals, Inc.'s total cost of revenue increased by 80.3% year-over-year, from $5.21M to $9.4M.
What does total cost of revenue mean?: The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.